Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Contrast Ultrasound for AAA Prediction
NCT02022436Phase 2Completed
- Start
- May 2012
- Primary completion
- Feb 2022
- Modality
- Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, open-label trial of perflutren lipid microspheres in abdominal aortic aneurysm (AAA) (2 arms). Primary endpoints: Annual Aneurysm Growth Rate Between Patients With and Without Micro Bubble Uptake at 5 years and Number of Participants With Microbubble Uptake at 6 months. Started May 2012; status: completed.
02
Drugs
perflutren lipid microspheres
03
Conditions
abdominal aortic aneurysm (AAA)
Beyond the preview
Go deeper on NCT02022436.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02022436.